Prosecutors say false conditions such as hypertension allegedly transformed cardiovascular screenings for otherwise healthy student athletes into reimbursable diagnostic claims submitted across the United States
WASHINGTON, DC — Federal prosecutors allege that cardiologist Jason Finkelstein and unidentified co-conspirators assigned false diagnoses to student athletes so insurers would pay for cardiovascular tests that had been marketed on college campuses as no-cost screenings.
The government says completed medical questionnaires were allegedly altered or coded to portray students as having conditions that justified diagnostic testing, although Finkelstein supposedly had not examined them or determined that individualized signs and symptoms required those procedures.
According to the federal indictment filed in the Southern District of Florida, the disputed diagnoses helped support claims sent to commercial insurers, the Federal Employees Health Benefits Program, the Veterans Health Administration, and Medicaid between January 2019 and December 2025.
Prosecutors allege the wider operation submitted more than $89 million in false claims and received more than $13.1 million, while approximately $1.1 million allegedly reached Finkelstein through checks and wire transfers connected with reimbursements.
Finkelstein has pleaded not guilty and remains presumed innocent, meaning the government must prove knowing fraud beyond a reasonable doubt rather than treating an inaccurate diagnosis, a standardized screening protocol, an ownership interest, or an administrative mistake as conclusive evidence.
Diagnosis Codes Allegedly Converted Screening into Diagnostic Care
The indictment describes a claimed conversion process in which campus events were promoted as screenings for cardiac abnormalities, while billing records allegedly presented participating athletes as patients who qualified for diagnostic cardiovascular testing under insurer medical-necessity rules.
That distinction matters because screening generally evaluates people without established symptoms, whereas diagnostic testing investigates a suspected condition supported by individualized history, examination findings, symptoms, prior results, or other clinically relevant evidence available before testing.
Prosecutors say false diagnosis codes supplied the missing clinical premise, allowing billers to associate electrocardiograms, echocardiograms, and several vascular ultrasound studies with conditions that supposedly made an otherwise noncovered screening panel eligible for payment.
The government must nevertheless identify the particular codes, questionnaires, claims, patients, and actors involved, because an allegation describing a repeated method cannot replace transaction-specific proof that a diagnosis was fabricated and materially influenced reimbursement.
Hypertension and Elevated Blood Pressure Were Reported Examples
Associated Press reporting on the prosecution says prosecutors identified hypertension and elevated blood pressure as examples of conditions allegedly submitted for athletes who did not actually have those diagnoses during the charged period.
Those examples matter because blood-pressure diagnoses can create an apparent clinical justification for additional cardiac or vascular evaluation, yet a responsible diagnosis ordinarily requires accurate measurements, appropriate context, professional judgment, and sometimes repeated assessment.
An isolated elevated reading can arise from exertion, anxiety, caffeine, pain, equipment problems, measurement technique, or temporary physiological circumstances, making the difference between an observation, a provisional concern, and a coded chronic diagnosis medically important.
Defense lawyers may therefore scrutinize whether any questionnaire disclosed prior readings, symptoms, medications, family history, or clinician advice, while prosecutors may compare original answers with later electronic entries to show deliberate and unsupported changes.
Completed Questionnaires Could Become Central Evidence
The indictment specifically alleges that false diagnosis codes were assigned to students’ completed medical questionnaires so employees of the unnamed Florida company could use those codes when preparing claims for public and private health benefit programs.
That wording places the questionnaires at a potentially decisive junction between what athletes actually reported, what company personnel entered into clinical systems, what Finkelstein could review, and what billers ultimately transmitted to insurers seeking payment.
Investigators may examine paper originals, electronic versions, scanned files, metadata, handwriting, audit histories, user credentials, timestamps, diagnosis tables, billing exports, and communications explaining who selected codes or instructed employees to change records before transmitting disputed claims.
The defense can test whether questionnaires were incomplete, whether software mapped responses automatically, whether coders exercised independent judgment, whether later corrections were preserved, and whether Finkelstein ever saw the versions used for disputed submissions.
Medical Necessity Required More Than a Billing Label
The indictment states that relevant health plans generally required a medical-necessity determination before reimbursing electrocardiograms, echocardiograms, or vascular ultrasounds, and usually did not cover screening tests performed without that individualized determination under their governing coverage requirements.
Prosecutors allege Finkelstein was identified as the only ordering or referring provider for the claims even though he did not conduct clinical examinations to determine whether athletes had symptoms or medical conditions warranting the tests.
A diagnosis code may help a claims system categorize an encounter, but it cannot retroactively create symptoms, substitute for an examination, establish that six separate procedures were appropriate, or prove that the ordering professional exercised individualized judgment.
At trial, clinical experts may explain which findings could reasonably support each procedure, while coding and payer experts may address what documentation was required and whether the challenged diagnoses were material to actual payment decisions.
The Same Six-Test Panel Allegedly Reached Almost Every Athlete
Federal prosecutors say traveling sonographers performed almost the same six cardiovascular tests on participating students, a pattern the government may use to argue that commercial volume preceded individualized diagnosis and clinical decision-making across distant college campuses.
Standardized testing is not inherently improper, because legitimate screening programs often apply consistent protocols to defined populations, but billing those services as individualized diagnostic care introduces additional obligations concerning necessity, ordering, documentation, coding, and disclosure.
The prosecution may compare diagnosis distributions with uniform procedure bundles to determine whether different purported conditions repeatedly produced identical testing, while the defense may identify established protocols or payer policies supporting particular combinations under specific circumstances.
Claims data alone will not reveal every clinical fact, so both sides may need athlete records, event files, images, questionnaires, consent materials, campus schedules, technician notes, physician reports, and insurer communications to reconstruct each disputed encounter.
Campus Marketing Allegedly Created the Patient Pipeline
The indictment says company personnel contacted athletic trainers with messages promising testing that could identify life-threatening conditions associated with sudden cardiac arrest, while portraying the services as carrying no cost for participating student athletes.
Prosecutors also allege that checks, wire transfers, gift cards, and other inducements were offered to athletic trainers or school personnel for referrals, and that students at certain institutions were told testing was mandatory for team participation.
Those allegations could help explain how large groups entered the workflow before any individualized clinical assessment occurred, although the government must still prove that particular referral practices and representations were connected with the charged fraudulent agreement.
Schools and athletes may have understood the events as preventive screenings, while insurers allegedly received claims portraying diagnostic services supported by medical conditions, creating a possible information divide central to the prosecution’s theory of deception.
No-Cost Language Did Not Mean No Financial Consequence
A student said that testing is free may reasonably believe nobody will receive a substantial bill, even though the provider may later submit multiple claims to an employer plan, public program, or family insurance policy.
Transparent consent should explain whether insurance will be billed, which entity will submit claims, which diagnoses could enter the medical record, whether cost sharing may arise, and how participants can obtain or correct their information.
The alleged scheme demonstrates why a promise of no immediate out-of-pocket expense cannot answer whether testing is clinically necessary, accurately coded, properly performed, meaningfully interpreted, and eligible under the participant’s specific coverage requirements.
Universities can reduce confusion by requiring vendors to provide sample claim disclosures, procedure lists, medical-necessity protocols, diagnosis practices, billing identities, and written explanations that distinguish preventive screening from reimbursable diagnostic care before granting campus access.
False Diagnoses Can Follow Patients Beyond a Single Claim
A fabricated or inaccurate condition may remain in electronic records long after an insurer processes the original claim, potentially influencing later treatment, medication decisions, risk assessments, referrals, insurance disputes, and a patient’s understanding of personal health.
For student athletes, an unsupported hypertension diagnosis could create anxiety, trigger unnecessary follow-up, conflict with future measurements, or require repeated explanations when clinicians, insurers, schools, and athletic programs review prior medical information during subsequent medical encounters.
The opposite danger also exists when a process designed around billing volume labels routine tests as normal without meaningful interpretation, because genuine abnormalities may be obscured while administrative records falsely project clinical reassurance.
Affected students should be able to obtain questionnaires, diagnosis lists, original images, signed reports, claim forms, explanation-of-benefits statements, and correction procedures without surrendering privacy or being forced to accept the provider’s characterization uncritically.
Electronic Audit Trails May Identify Who Changed What
Modern clinical and billing systems can record user logins, field changes, code selections, report approvals, export times, claim transmissions, denials, appeals, and corrections, potentially allowing investigators to trace a diagnosis from questionnaire through payment.
Prosecutors may seek evidence showing repeated edits by the same personnel, instructions to use particular codes, diagnoses added after tests occurred, copied narratives, unusual distributions, or changes made immediately before claim submission to insurers seeking reimbursement.
Defense experts may identify shared accounts, automated mappings, software defaults, migrated data, batch processing, vendor interfaces, inconsistent timestamps, or access events that do not reliably show who made a substantive clinical decision.
Digital evidence becomes persuasive only when authenticated and interpreted within the actual workflow, because an account name may identify a credential without proving who used it, what information appeared onscreen, or why a field changed.
Billers and Coders May Explain the Alleged Conversion Process
Employees who prepared claims could testify about the information they received, code-selection instructions, supervisory practices, rejected submissions, appeals, software limitations, performance incentives, and whether anyone questioned diagnoses unsupported by athlete questionnaires during the charged workflow.
Their testimony may help prosecutors connect clinical records with interstate claims, but defense attorneys can examine inconsistent recollections, cooperation agreements, personal responsibility, training deficiencies, and whether witnesses interpreted ambiguous directions through later investigative pressure.
Billing vendors may also possess implementation documents, data dictionaries, claim edits, support tickets, account records, and correspondence showing whether diagnosis fields originated with company employees, automated systems, Finkelstein, or another professional during each disputed encounter.
Because corporate workflows divide responsibilities, the government must prove knowing participation rather than relying solely upon Finkelstein’s ownership of the Texas professional associations or his position as medical director of the unnamed Florida company.
Materiality Will Be Tested Payer by Payer
Federal healthcare-fraud charges require more than an inaccurate statement, because prosecutors must establish that the alleged falsehood was material to the health benefit program’s decision involving delivery of or payment for covered services.
Commercial plans, federal employee coverage, veterans’ benefits, and Medicaid arrangements may apply different guidelines, contracts, enrollment rules, coding edits, authorization processes, and definitions of medical necessity across states and plan years throughout the alleged multistate operation.
The prosecution may use policy manuals, claim adjudication records, payer witnesses, denial letters, appeal files, and coverage guidelines to demonstrate that a truthful description of asymptomatic screening would have produced denial or additional review.
The defense may argue that certain tests would have been covered under other criteria, that insurers knew the campus workflow, that diagnosis codes did not determine payment, or that disputed entries were immaterial administrative errors.
Intent Separates Fraud from Negligence or Coding Error
Healthcare records frequently contain mistakes, and federal criminal liability does not arise merely because a code was inaccurate, documentation was incomplete, a workflow was poorly supervised, or professional judgment later appears questionable under federal criminal statutes.
Prosecutors must show that Finkelstein knowingly and willfully participated in the alleged conspiracy and executions, while the defense can argue reasonable reliance on managers, coders, billers, technicians, software vendors, or other professionals handling administrative details.
Evidence of repeated practices, financial compensation, internal warnings, ownership control, appeals, rapid approvals, or continued conduct after identified problems may support an inference of knowledge, depending on authenticity and the surrounding context of the alleged conspiracy.
Conversely, evidence of compliance advice, delegated responsibilities, corrective measures, inconsistent practices, legitimate examinations, or independent coding decisions could weaken the proposition that one coordinated plan generated every disputed diagnosis and claim during the charged period.
Place-of-Service Information Adds Another Alleged Falsehood
The indictment alleges claims included place-of-service codes and related information suggesting athletes received testing at Finkelstein’s office in Tarrant County, Texas, although sonographers actually acquired images during campus events elsewhere in the country.
Location information can influence network treatment, reimbursement methodology, enrollment, credentialing, technical-component rules, supervision requirements, and state jurisdiction, making an inaccurate service address potentially material beyond the diagnosis field itself for every disputed claim.
Prosecutors may combine the allegedly false diagnoses with disputed locations and physician-role descriptions to present a coordinated claim narrative, while defense lawyers may argue that separate software defaults or billing conventions explain individual fields.
Jurors will need instructions preventing them from treating one proven inaccuracy as automatic proof of every other allegation, because each representation, actor, transaction, and mental state requires evidence under the charged federal statutes.
Nationwide Licensing Allegedly Expanded the Diagnosis Pipeline
Finkelstein’s licenses across the forty-eight contiguous states allegedly enabled claims involving students at schools nationwide, giving the operation a physician whose professional authority could accompany a geographically dispersed testing and billing model during the charged period.
Multistate licensing is lawful and often essential for telemedicine, remote interpretation, and mobile services, so the existence of many licenses cannot establish that diagnoses were false, tests unnecessary, or claims knowingly fraudulent under federal healthcare law.
The government may nevertheless argue that broad licensure provided infrastructure through which the same questionnaire, coding, testing, and approval process could scale rapidly across jurisdictions without a corresponding expansion of individualized clinical assessment at a comparable national scale.
The defense may demonstrate legitimate reasons for maintaining those licenses and challenge whether state authority, patient location, corporate roles, technician qualifications, or payer enrollment actually operated as prosecutors describe for particular claims during the charged years.
Rapid Approvals Allegedly Undermined the Clinical Narrative
Prosecutors allege Finkelstein routinely signed cardiovascular results within seconds of accessing them, even though claims allegedly identified him as a reviewing provider responsible for meaningfully interpreting complex diagnostic studies under the alleged workflow.
The government may contend that rapid approvals contradict claim records showing carefully ordered and reviewed diagnostic care, particularly when those records also included conditions that supposedly warranted extensive cardiovascular investigation for young athletes under applicable coverage rules.
Defense experts can examine whether images were reviewed earlier, whether preliminary readers participated, whether platform timestamps captured only final signature events, and whether some studies required less time than prosecutors suggest during actual clinical workflows.
The timing evidence must be evaluated study by study, because an unusually short electronic interval may support suspicion without independently proving a fabricated diagnosis, an unread image, or a knowingly false claim under federal criminal law.
One Athlete’s Death Intensifies the Safety Questions
The indictment describes an October 2024 test collection containing approximately sixty-three images, some bearing unconfirmed references to possible right atrial and right ventricular hypertrophy before Finkelstein allegedly signed the results as normal eleven seconds after access.
Prosecutors say the athlete died from sudden cardiac arrest approximately twenty-four days later, and they allege Finkelstein continued approving other students’ tests without meaningful review after learning of the death and the family’s concerns.
That episode gives the case profound human gravity, but it does not independently prove the diagnosis-coding allegations, causation, criminal intent, or the elements associated with any other athlete’s insurance submission during the charged period.
Defense counsel may challenge image quality, preliminary annotations, platform timing, medical significance, cause of death, intervening events, professional responsibilities, and whether the government’s billing theory can be inferred from a tragic clinical outcome.
The Financial Allegations Depend on Claim-Level Proof
Prosecutors allege more than $89 million in false claims generated more than $13.1 million in payments to accounts belonging to Cardiovascular Testing Services PA and Cardiovascular Healthcare Associates PA, two Texas entities owned by Finkelstein.
Those figures describe submitted charges and reimbursements rather than proven theft or personal profit, while the indictment separately alleges approximately $1.1 million was paid to Finkelstein through checks and wires during the charged period.
Forensic accountants may match diagnosis codes, test panels, service locations, physician identifiers, claim dates, payments, denials, appeals, and outgoing transfers to determine which financial transactions followed allegedly fabricated conditions under the alleged operation.
Defense experts may separate legitimate services, denied claims, contractual adjustments, reversed payments, differing coverage rules, and compensation for lawful work, resisting any attempt to let aggregate totals substitute for count-specific evidence under federal fraud law.
Three Substantive Counts Narrow the Government’s Case
Alongside one conspiracy count, the indictment charges three substantive healthcare-fraud executions involving two abdominal aorta ultrasound claims and one cardiovascular panel associated with the athlete identified only by initials in the public filing.
The billed amounts listed for those claims are approximately $150, $150, and $975, illustrating the considerable distance between the selected transactions and the government’s broader allegation involving more than $89 million submitted during the charged conspiracy.
Jurors must assess each count separately, determining whether the services were medically necessary, eligible for reimbursement, provided as represented, and connected with knowingly false pretenses attributable to Finkelstein under the governing instructions for each selected transaction.
The defense can insist that generalized evidence about diagnoses or national patterns cannot replace proof concerning those claims, while prosecutors may use the alleged common workflow to explain why selected transactions represented intentional executions.
Schools Can Strengthen Oversight Before Campus Testing
Colleges evaluating cardiovascular vendors should verify physician licenses, technician credentials, clinical protocols, diagnosis practices, referral compensation, insurance billing, consent language, data handling, result interpretation, and urgent follow-up procedures before scheduling events for participating student athletes.
Contracts should identify who determines medical necessity, who selects diagnoses, where each service occurs, which entity submits claims, what students may owe, and how inaccurate records will be corrected promptly through accessible written procedures.
Athletic departments should preserve proposals, credential files, event rosters, questionnaires, consent forms, equipment logs, claim disclosures, payment arrangements, incident reports, and communications so later concerns can be investigated through contemporaneous evidence during any subsequent investigation.
Schools should never assume that a national footprint, extensive physician licensing, sophisticated marketing presentation, or no-cost promise independently verifies that every clinical and billing representation satisfies local and payer-specific requirements across every participating campus.
Athletes Deserve Plain-Language Disclosure and Record Access
Before participating, students should receive understandable explanations of whether testing is optional, what clinical purpose each procedure serves, who will perform and interpret it, and whether insurance will receive diagnostic claims following the campus event.
They should also know what diagnoses may be entered, how those conditions were determined, whether findings affect team eligibility, how abnormal results will be escalated, and where to obtain complete images and reports.
After testing, athletes should compare explanation-of-benefits statements with the services they remember receiving and promptly question unfamiliar diagnoses, unexpected locations, unknown providers, duplicate procedures, or claim dates that appear inaccurate within their insurance records.
Privacy protections remain essential during any review, because student health information should not become public simply because a vendor faces criminal allegations or a school examines whether its oversight processes met applicable confidentiality rules.
Insurers Can Detect Diagnosis Patterns Earlier
Health plans can compare diagnosis frequencies, athlete ages, identical test bundles, school event dates, ordering-provider concentration, service locations, technician identities, review intervals, denial histories, appeals, and related corporate addresses across claims during each plan year.
Patterns such as sudden clusters of hypertensions among young athletic populations may justify focused review, but statistical anomalies should trigger verification rather than automatic accusations because legitimate programs can produce concentrated and unusual data.
Payers should communicate clear prospective rules for preventive screening, diagnostic testing, required examinations, acceptable documentation, mobile services, remote interpretation, professional and technical components, and claim location fields before disputes accumulate across participating health plans.
Coordination among clinical review, credentialing, claims operations, data analytics, provider education, and special investigations can identify questionable coding earlier while giving honest providers a fair opportunity to explain atypical practices before substantial payments accumulate.
Healthcare Organizations Need Controls Around Diagnosis Creation
Providers should restrict diagnosis entry to appropriately trained personnel, preserve the original patient responses, document the clinical basis for every condition, and record who reviewed or changed each code before billing through documented approval procedures.
Electronic systems should flag diagnoses added after service completion, codes unsupported by recorded findings, identical conditions assigned across large screening cohorts, and claims inconsistent with the encounter’s stated preventive purpose before any claim submission.
Independent sampling should compare questionnaires, clinician notes, test orders, images, reports, claim forms, and payer outcomes, allowing compliance personnel to identify whether workflow shortcuts are producing inaccurate records or reimbursement exposure during routine internal audits.
Training must emphasize that diagnosis codes are not merely financial labels, because they communicate clinical assertions that can affect patient care, legal duties, insurance decisions, and the long-term integrity of health records throughout subsequent healthcare encounters.
Public Reporting Must Preserve the Presumption of Innocence
Responsible coverage should attribute the fabricated-diagnosis claim to prosecutors, distinguish the indictment from proven evidence, and avoid describing every student as healthy when individual medical histories have not received public adversarial examination before evidence is tested.
Journalists should also separate screening from diagnostic testing, submitted claims from payments, corporate receipts from personal compensation, and questionable documentation from criminal intent, because collapsing those categories can distort both prosecution and defense positions.
The examples of hypertension and elevated blood pressure come from reporting about the government’s allegations, while the indictment publicly describes the broader method of assigning false codes to completed questionnaires without listing every disputed condition.
Finkelstein has no obligation to prove innocence, and the government must prove the alleged agreement, knowing participation, material falsehoods, interstate executions, and each substantive count beyond a reasonable doubt at trial.
Crisis Communication Should Follow Verifiable Evidence
Healthcare organizations, colleges, and professionals responding to comparable accusations need coordinated communication that protects patient privacy, preserves documents, avoids influencing witnesses, acknowledges verified facts, and resists premature declarations of guilt or exoneration during continuing public scrutiny.
Amicus International Consulting’s crisis public relations guidance emphasizes structured assessment and planned stakeholder communication, principles that can support responsible responses while lawyers, clinicians, and auditors evaluate records during extended litigation and regulatory review.
Its approach to rebuilding a damaged public reputation similarly favors sustained and verifiable communication, although ethical reputation work cannot erase authentic records, manufacture clinical support, suppress legitimate reporting, or replace corrective action after proven misconduct.
Institutions should explain what records they preserve, how affected students can request information, whether independent clinical review is available, and what oversight improvements have occurred, without speculating about unresolved criminal responsibility during the pending prosecution.
The Diagnosis Allegation Awaits Jury Testing
The case remains pending before Judge Aileen Cannon in West Palm Beach, with a status conference scheduled for September 16, 2026, a calendar call set for March 30, 2027, and trial currently scheduled for April 5, 2027.
Those dates may change through later orders as discovery, expert analysis, evidentiary motions, witness preparation, and possible negotiations determine whether the government’s diagnosis theory reaches jurors in its present form before the scheduled trial.
Prosecutors may present questionnaires, audit trails, claims, payer rules, employee testimony, financial records, rapid approvals, and repeated coding patterns as interconnected evidence that diagnoses were deliberately created to unlock reimbursement during the charged period.
Defense lawyers may challenge authenticity, attribution, medical necessity, materiality, software behavior, delegated responsibilities, witness credibility, legitimate service value, and whether administrative shortcomings prove the knowing intent required for federal fraud beyond reasonable doubt.
The ultimate question will require precision rather than rhetoric, because jurors must connect identifiable diagnosis entries with actual students, controlling coverage requirements, particular claims, payment decisions, and Finkelstein’s knowledge before finding criminal liability.
Until that evidence is tested, the allegation that hypertension and other conditions were fabricated for student athletes remains an accusation, and Jason Finkelstein remains presumed innocent unless the government proves every charged element beyond a reasonable doubt.
